Atherosclerosis as a paradigmatic disease of the elderly: Role of the immune system

Immunology and Allergy Clinics of North America

Volumn 23, Issue 1, 2003, Pages 117-132

  Knoflach, Michael ^a   Mayrl, Bruno ^a   Mayerl, Christina ^b   Sedivy, Roland ^c   Wick, Georg ^a,b  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 60;

AGE; ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CROSS REACTION; DISEASE ASSOCIATION; ELDERLY CARE; ENDOTHELIUM CELL; HEART INFARCTION; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRESS; STROKE; SURVIVAL; SYMPTOMATOLOGY;

AGED; AGING; ARTERIOSCLEROSIS; AUTOIMMUNITY; CHAPERONIN 60; HUMANS;

EID: 0037325425     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00077-2     Document Type: Review

References (108)

1. American Heart Association. 2002 Heart and stroke statistical update. Dallas (TX): American Heart Association; 2001.
2. Burke AP, Farb A, Virmani R, et al. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 1991;121(2 Pt 1):568-75.
3. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338(23):1650-6.
4. Gaeta G, De Michele M, Cuomo S, et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000;343(12):840-6.
5. Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001;104(6):653-7.
6. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103(22):2705-10.
7. Smilde TJ, van Wissen S, Wollersheim H, et al. Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia. Neth J Med 2001;59(4):184-95.
8. McGill Jr HC, McMahan CA, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20(8):1998-2004.
9. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002;160(2):441-8.
10. Millonig G, Schwentner C, Mueller P, et al. The vascular-associated lymphoid tissue: a new site of local immunity. Curr Opin Lipidol 2001;12(5):547-53.
11. Wick G, Kleindienst R, Dietrich H, et al. Is atherosclerosis an autoimmune disease? Trends Food Science Technology 1992;3:114-9.
12. Virchow R. Cellular pathology as based upon physiological and pathological histology [English translation of second German edition]. 1971. Philadelphia: JB Lippincott; 1971.
13. Rokitansky C. Handbuch der pathologischen Anatomie. Vienna: Braumüller & Seidel; 1846.
14. Osler W. Diseases of the arteries. In: Osler W, MacCrae T, editors. Modern medicine. Its theory and practice in original contributions by Americans and foreign authors. vol 4. Philadelphia: Lea & Fiebiger; 1908. p. 426-47.
15. Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med 1978; 148(1):335-40.
16. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989;225(5):293-6.
17. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105(9): 1135-43.
18. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(12):1876-90.
19. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340(2):115-26.
20. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999;10(Suppl 1):S9-12.
21. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350(9075):430-6.
22. Nieto FJ. Viruses and atherosclerosis: a critical review of the epidemiologic evidence. Am Heart J 1999;138(5 Pt 2):S453-60.
23. Stary HC. Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol 2000;89(Suppl 2):28-35.
24. Vlaicu R, Niculescu F, Rus HG, et al. Immune deposits in human aortic atherosclerotic wall. Med Interne 1983;21(1):3-8.
25. Emeson EE, Robertson Jr AL. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 1988;130(2):369-76.
26. Xu QB, Oberhuber G, Gruschwitz M. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 1990;56(3):344-59.
27. Lord RS, Bobryshev YV. Clustering of dendritic cells in athero-prone areas of the aorta. Atherosclerosis 1999;146(1):197-8.
28. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992;12(2):206-11.
29. Gupta S, Pablo AM, Jiang X, et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997;99(11):2752-61.
30. Whitman SC, Ravisankar P, Elam H, et al. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 2000;157(6):1819-24.
31. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992;12(7): 789-99.
32. Wick G, Kleindienst R, Schett G, et al. Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. Int Arch Allergy Immunol 1995;107(1-3):130-1.
33. Xu Q, Kleindienst R, Schett G, et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 1996;123(1-2):145-55.
34. Afek A, George J, Gilburd B, et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 2000;14(2):115-21.
35. George J, Afek A, Gilburd B, et al. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol 2001;38(3):900-5.
36. Young DB. Heat-shock proteins: immunity and autoimmunity. Curr Opin Immunol 1992;4(4): 396-400.
37. Jones DB, Coulson AF, Duff GW. Sequence homologies between HSP60 and autoantigens. Immunol Today 1993;14(3):115-8.
38. Jindal S, Malkovsky M. Stress responses to viral infection. Trends Microbiol 1994;2(3):89-91.
39. Kaufmann SH, Schoel B, van Embden JD, et al. Heat-shock protein 60: implications for pathogenesis of and protection against bacterial infections. Immunol Rev 1991;121:67-90.
40. Amberger A, Maczek C, Jurgens G, et al. Co-expression of ICAM-1, VCAM-1, ELAM-1 and HSP60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 1997;2(2):94-103.
41. Wick G, Perschinka H, Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol 2001;22(12):665-9.
42. Kleindienst R, Schett G, Amberger A, et al. Atherosclerosis as an autoimmune condition. Isr J Med Sci 1995;31(10):596-9.
43. Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000;102(1):14-20.
44. Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91(4):281-91.
45. Witztum JL, Palinski W. Are immunological mechanisms relevant for the development of atherosclerosis? Clin Immunol 1999;90(2):153-6.
46. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995;92(3):821-5.
47. George J, Shoenfeld Y, Afek A, et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 1999;19(3):505-10.
48. George J, Afek A, Gilburd B, et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 1998;138(1):147-52.
49. Feige U, van Eden W. Infection, autoimmunity and autoimmune disease. EXS 1996;77:359-73.
50. Wick G, Romen M, Amberger A, et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 1997;11(13):1199-207.
51. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996;2(9):372-9.
52. Zou Y, Dietrich H, Hu Y, et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153(4):1301-10.
53. Dietrich H, Hu Y, Zou Y, et al. Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000;157(2):659-69.
54. Zou Y, Hu Y, Mayr M, et al. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 2000;86(4):434-40.
55. Seitz CS, Kleindienst R, Xu Q, et al. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab Invest 1996;74(1):241-52.
56. Dansky HM, Charlton SA, Harper MM, et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997;94(9):4642-6.
57. -/- mice. J Clin Invest 1997;100(6):1575-80.
58. Metzler B, Mayr M, Dietrich H, et al. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler Thromb Vasc Biol 1999;19(8):1905-11.
59. Wick G. Correction for Metzler et al. Arterioscler Thromb Vasc Biol 1999;19(8):1905-11. Arterioscler Thromb Vasc Biol 2001;(21):1706.
60. Wick G. Correction for Metzler et al. Arterioscler Thromb Vasc Biol 1999;19(8):1905-11. Arterioscler Thromb Vasc Biol 2001;(21):1706.
61. Amberger A, Hala M, Saurwein-Teissl M, et al. Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol Med 1999;5(2): 117-28.
62. Soltys BJ, Gupta RS. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int 1997;21(5):315-20.
63. Xu Q, Schett G, Seitz CS, et al. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 1994;75(6):1078-85.
64. Schett G, Xu Q, Amberger A, et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995;96(6):2569-77.
65. Schett G, Metzler B, Mayr M, et al. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 1997;128(1):27-38.
66. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb 1993;13(5):661-8.
67. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993;341(8840):255-9.
68. Mayr M, Metzler B, Kiechl S, et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999; 99(12):1560-6.
69. Metzler B, Schett G, Kleindienst R, et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17(3):536-41.
70. Schett G, Metzler B, Kleindienst R, et al. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to atherosclerosis. Int Arch Allergy Immunol 1997;114(3): 246-50.
71. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, et al. Crossreactive b-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscl Thromb Vasc Biol, submitted.
72. Xu Q, Kiechl S, Mayr M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999; 100(11):1169-74.
73. Rea IM, McNerlan S, Pockley AG. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol 2001;36(2):341-52.
74. Hoppichler F, Koch T, Dzien A, et al. Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 2000;94(4):220-3.
75. Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19(3):387-94.
76. Prohaszka Z, Duba J, Lakos G, et al. Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol 1999;11(9):1363-70.
77. Hoppichler F, Lechleimer M, Traweger C, et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996; 126(2):333-8.
78. Schett G, Metzler B, Kleindienst R, et al. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc Res 1999; 42(3):685-95.
79. Kinane DF, Lowe GD. How periodontal disease may contribute to cardiovascular disease. Periodontol 2000;23:121-6.
80. Beck JD, Pankow J, Tyroler HA, et al. Dental infections and atherosclerosis. Am Heart J 1999; 138(5 Pt 2):S528-33.
81. Mayr M, Kiechl S, Willeit J, et al. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102(8):833-9.
82. Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998;98(4):300-7.
83. Chen W, Syldath U, Bellmann K, et al. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999;162(6):3212-9.
84. Kol A, Bourcier T, Lichtman AH, et al. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999; 103(4):571-7.
85. Mosorin M, Surcel HM, Laurila A, et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 2000;20(4):1061-7.
86. Curry AJ, Portig I, Goodall JC, et al. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 2000;121(2): 261-9.
87. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96(11):4095-103.
88. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103(8):1064-70.
89. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;348(9027):567-72.
90. Kuller LH, Meilahn EN. Risk factors for cardiovascular disease among women. Curr Opin Lipidol 1996;7(4):203-8.
91. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148(2):209-14.
92. Bozzini C, Girelli D, Tinazzi E, et al. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem 2002;48(4):622-8.
93. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2(8618):983-6.
94. Cook PJ, Honeyboume D, Lip GY, et al. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998;29(2):404-10.
95. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92(12):3397-400.
96. Godzik KL, O'Brien ER, Wang SK, et al. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33(9):2411-4.
97. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97(7):633-6.
98. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96(2):404-7.
99. Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97(17):1675-9.
100. Folsom AR, Nieto FJ, Sorlie P, et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998;98(9):845-50.
101. Petrie BL, Melnick JL, Adam E, et al. Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis 1987;155(1):158-9.
102. Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 1999;100(14):1569-75.
103. Yamashiroya HM, Ghosh L, Yang R, et al. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988;130(1):71-9.
104. Hajjar DP. Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. Am J Pathol 1991;139(6):1195-211.
105. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M, et al. Cardiovascular risk factors and early atherosclerosis in young males. Lancet; submitted.
106. Nesse RM, Williams GC. Evolution and the origins of disease. Sci Am 1998;279(5):86-93.
107. Olshansky JS, Carnes BA, Butler RN. If humans were built to last. Sci Am 2001;284(3):50-5.
108. Wick G. A Darwinian-evolutionary concept of age-related diseases. Exp Gerontol 2003;38, in press.